Skip to content

David A. Alagpulinsa, PhD

Principal Investigator

Dr. Alagpulinsa is a recipient of the MGH Physician-Scientist Development Award and was the MGH nominee for the American Diabetes Association Pathway to Stop Diabetes Award in 2019. He also won the MGH Tosteson and Fund for Medical Discovery Fellowship Award, as well as the MGH SAC Poster of Distinction awards in 2018 and 2021.

Dr. Alagpulinsa’s current research focuses on regenerative and cell replacement therapies for type 1 diabetes, a chronic disease that results from autoimmune-mediated destruction of insulin-producing beta cells of the pancreatic islets.

Prior Experience

After graduating from the University of Arkansas for Medical Sciences, Dr. Alagpulinsa completed a one-year postdoctoral fellowship in medical oncology at Dana Farber Cancer Institute before joining VIC in September 2016.

Academic Credentials

Outside of VIC

Outside of academic research, Dr. Alagpulinsa is very keen about activities and programs that champion diversity, equity, and inclusion. He is an active member of the Harvard Black Postdoctoral Association, especially the organizing committee, and volunteers as a Science Fair Judge for predominantly minority/black elementary schools in the Boston neighborhood.